» Articles » PMID: 22031471

Functional Status of Somatodendritic Serotonin 1A Autoreceptor After Long-term Treatment with Fluoxetine in a Mouse Model of Anxiety/depression Based on Repeated Corticosterone Administration

Overview
Journal Mol Pharmacol
Date 2011 Oct 28
PMID 22031471
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Most preclinical studies investigating the effects and the mechanism of action of antidepressants have been performed in naive rodents. This is inappropriate because antidepressants act on specific symptoms of the pathological condition, such as distress and anxiety. We have developed a mouse model of anxiety/depression based on addition of corticosterone to drinking water. This model is highly reproducible and easy to set up compared with unpredictable chronic mild stress. The serotonin 1A (5-HT(1A)) autoreceptor is known to play a role in mood disorders and their treatments. An increase in somatodendritic 5-HT(1A) autoreceptor density in the dorsal raphe (DR) attenuates the therapeutic activity of selective serotonin-reuptake inhibitors (SSRIs), whereas their functional desensitization promotes activation of brain serotonergic transmission, thereby representing an adaptive change relevant to their therapeutic effect. Here we assessed the effects of sustained administration of the SSRI fluoxetine on 5-HT(1A) autoreceptor sensitivity in mice administered with corticosterone. Fluoxetine attenuated hypothermia induced by the 5-HT(1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin, decreased DR 5-HT neuronal activity, and decreased 5-HT release in both vehicle- and corticosterone-pretreated mice. However, such desensitization was more pronounced in corticosterone-pretreated mice. This change had an overall effect on serotonergic tone because we found a greater firing rate of 5-HT neurons associated with an enhancement of 5-HT outflow in the DR of corticosterone-pretreated mice in response to fluoxetine compared with the corresponding group of vehicle-pretreated mice. These results provide cellular explanations for the antidepressant effects produced by SSRIs in subjects with pathological conditions but not in naive animals or healthy volunteers.

Citing Articles

Chronic Desipramine Reverses Deficits in Cell Activity, Norepinephrine Innervation, and Anxiety-Depression Phenotypes in Fluoxetine-Resistant cF1ko Mice.

Vahid-Ansari F, Zahrai A, Daigle M, Albert P J Neurosci. 2023; 44(3).

PMID: 38050173 PMC: 10860653. DOI: 10.1523/JNEUROSCI.1147-23.2023.


Enriched environmental exposure reduces the onset of action of the serotonin norepinephrin reuptake inhibitor venlafaxine through its effect on parvalbumin interneurons plasticity in mice.

Coutens B, Lejards C, Bouisset G, Verret L, Rampon C, Guiard B Transl Psychiatry. 2023; 13(1):227.

PMID: 37365183 PMC: 10293286. DOI: 10.1038/s41398-023-02519-x.


Role of 5-HT1A-mediated upregulation of brain indoleamine 2,3 dioxygenase 1 in the reduced antidepressant and antihyperalgesic effects of fluoxetine during maintenance treatment.

Dai J, Kim H, You Z, McCabe M, Zhang S, Wang S Front Pharmacol. 2023; 13:1084108.

PMID: 36588734 PMC: 9800882. DOI: 10.3389/fphar.2022.1084108.


Sex and social status modify the effects of fluoxetine on socioemotional behaviors in Syrian hamsters and rhesus macaques.

Voisin D, Wakeford A, Nye J, Mun J, Jones S, Locke J Pharmacol Biochem Behav. 2022; 215:173362.

PMID: 35219757 PMC: 8983589. DOI: 10.1016/j.pbb.2022.173362.


Inhibition of Connexin 36 attenuates HMGB1-mediated depressive-like behaviors induced by chronic unpredictable mild stress.

Jiang Q, Li C, Zeng W, Xu H, Li J, Zhang T Brain Behav. 2022; 12(2):e2470.

PMID: 35089644 PMC: 8865165. DOI: 10.1002/brb3.2470.